Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05657_nanopub.RAeSN7yja0SyWZKycEos5CRnXNG81t6umwI9Tz4m7KQ4I#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05657 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05657 label "TZP-101 [drugbank:DB05657]" assertion.
- drugbank:DB05657 seeAlso DB05657 assertion.
- drugbank:DB05657 description "TZP-101 is a novel small molecule ghrelin agonist being developed by Tranzyme Pharma as a first-in-class treatment for both POI and diabetic gastroparesis, serious medical conditions in which motility of the GI tract is severely impaired." assertion.
- drugbank:DB05657 identifier "drugbank:DB05657" assertion.
- drugbank:DB05657 title "TZP-101" assertion.
- drugbank:DB05657 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05657 drugbank_vocabulary:drugbank-id "DB05657" assertion.
- drugbank:DB05657 bio2rdf_vocabulary:x-identifiers.org DB05657 assertion.
- drugbank:DB05657 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05657" assertion.
- drugbank:DB05657 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05657 bio2rdf_vocabulary:identifier "DB05657" assertion.